Taste Disturbance in Patients with Advanced Cancer: a Scoping Review of Clinical Features and Complications

Overview

Journal Support Care Cancer

Specialties Critical Care
Oncology

Date 2023 Sep 6

PMID 37672147

Authors

Marie Hannon

Annelie Shaw

Michael Connolly

Andrew Davies

Affiliations

Soon will be listed here.

Abstract

Purpose: The purpose of this scoping review is to appraise the published literature on taste disturbance in patients with advanced cancer, with the specific objectives being to determine its prevalence, clinical features and complications.

Methods: This scoping review was conducted using the recommended methodological framework. A detailed search of databases (Medline, Embase, CINAHL and PsycInfo) was conducted to identify eligible studies: eligible studies needed to include patients with advanced cancer and needed to include details of clinical features and/or complications of taste disturbance. Standard bibliographic/systematic review software was used to store the records and manage the review process, respectively.

Results: Twenty-five studies were identified from the database searches. The studies identified included eight physical and/or psychological symptom studies, six symptom cluster studies, five oral symptom studies and six taste and/or smell specific studies. Detailed data is presented on the clinical features and complications of taste disturbance and on the symptom clusters involving taste disturbance in this cohort of patients.

Conclusion: This scoping review identified a relatively small number of relevant studies involving a relatively small number of participants. Nevertheless, it confirms that taste disturbance is a common problem in patients with advanced cancer and is associated with significant morbidity because of the primary condition and the associated complications.

Citing Articles

Symptom clusters and network analysis of patients with intermediate and advanced liver cancer treated with targeted immunotherapy.

Chen M, Li S, Jin G, Li R, Qi Z, He Y Support Care Cancer. 2024; 32(9):580.

PMID: 39115725 DOI: 10.1007/s00520-024-08784-w.

Taste and Smell Alterations (TSAs) in Cancer Patients.

Rosati D, Mastino P, Romeo M, de Soccio G, Pentangelo D, Petrella C Diseases. 2024; 12(6).

PMID: 38920562 PMC: 11203271. DOI: 10.3390/diseases12060130.

Taste disturbance in patients with advanced cancer: who gets it?.

Davies A, Cleary N, Hannon M, Webber K Support Care Cancer. 2023; 32(1):17.

PMID: 38091093 DOI: 10.1007/s00520-023-08244-x.

References

Spotten L, Corish C, Lorton C, Ui Dhuibhir P, ODonoghue N, OConnor B . Subjective and objective taste and smell changes in cancer. Ann Oncol. 2017; 28(5):969-984. DOI: 10.1093/annonc/mdx018. View

Tsai J, Wu C, Chiu T, Chen C . Significance of symptom clustering in palliative care of advanced cancer patients. J Pain Symptom Manage. 2010; 39(4):655-62. DOI: 10.1016/j.jpainsymman.2009.09.005. View

Dong S, Butow P, Costa D, Lovell M, Agar M . Symptom clusters in patients with advanced cancer: a systematic review of observational studies. J Pain Symptom Manage. 2014; 48(3):411-50. DOI: 10.1016/j.jpainsymman.2013.10.027. View

Alt-Epping B, Nejad R, Jung K, Gross U, Nauck F . Symptoms of the oral cavity and their association with local microbiological and clinical findings--a prospective survey in palliative care. Support Care Cancer. 2011; 20(3):531-7. PMC: 3271219. DOI: 10.1007/s00520-011-1114-z. View

Jones J, Chavarri-Guerra Y, Correa L, Dean D, Epstein J, Fregnani E . MASCC/ISOO expert opinion on the management of oral problems in patients with advanced cancer. Support Care Cancer. 2022; 30(11):8761-8773. PMC: 9633484. DOI: 10.1007/s00520-022-07211-2. View

Breslin P, Spector A . Mammalian taste perception. Curr Biol. 2008; 18(4):R148-55. DOI: 10.1016/j.cub.2007.12.017. View

Zhou T, Yang K, Thapa S, Liu H, Wang B, Yu S . Differences in Symptom Burden Among Cancer Patients With Different Stages of Cachexia. J Pain Symptom Manage. 2017; 53(5):919-926. DOI: 10.1016/j.jpainsymman.2016.12.325. View

Webber K, Davies A, Leach C, Waghorn M . Symptom prevalence and severity in palliative cancer medicine. BMJ Support Palliat Care. 2021; 13(e2):e270-e272. DOI: 10.1136/bmjspcare-2020-002357. View

Galaniha L, Nolden A . Taste loss in cancer patients: clinicians' perceptions of educational materials and diagnostic tools. Support Care Cancer. 2023; 31(6):349. PMC: 10206338. DOI: 10.1007/s00520-023-07794-4. View

10.

Alsirafy S, Abd El-Aal H, Farag D, Radwan R, El-Sherief W, Fawzy R . High Symptom Burden Among Patients With Newly Diagnosed Incurable Cancer in a Developing Country. J Pain Symptom Manage. 2016; 51(5):e1-5. DOI: 10.1016/j.jpainsymman.2016.02.003. View

11.

Sweeney M, Bagg J, Baxter W, Aitchison T . Oral disease in terminally ill cancer patients with xerostomia. Oral Oncol. 1998; 34(2):123-6. DOI: 10.1016/s1368-8375(97)00076-6. View

12.

Boltong A, Keast R, Aranda S . A matter of taste: making the distinction between taste and flavor is essential for improving management of dysgeusia. Support Care Cancer. 2011; 19(4):441-2. DOI: 10.1007/s00520-011-1085-0. View

13.

Mahmoud F, Aktas A, Walsh D, Hullihen B . A pilot study of taste changes among hospice inpatients with advanced cancer. Am J Hosp Palliat Care. 2011; 28(7):487-92. DOI: 10.1177/1049909111402187. View

14.

Van Lancker A, Beeckman D, Van Den Noortgate N, Verhaeghe S, Van Hecke A . Frequency and intensity of symptoms and treatment interventions in hospitalized older palliative cancer patients: a multicentre cross-sectional study. J Adv Nurs. 2016; 73(6):1455-1466. DOI: 10.1111/jan.13230. View

15.

Gunn L, Gilbert J, Nenclares P, Soliman H, Newbold K, Bhide S . Taste dysfunction following radiotherapy to the head and neck: A systematic review. Radiother Oncol. 2021; 157:130-140. DOI: 10.1016/j.radonc.2021.01.021. View

16.

Tranmer J, Heyland D, Dudgeon D, Groll D, Squires-Graham M, Coulson K . Measuring the symptom experience of seriously ill cancer and noncancer hospitalized patients near the end of life with the memorial symptom assessment scale. J Pain Symptom Manage. 2003; 25(5):420-9. DOI: 10.1016/s0885-3924(03)00074-5. View

17.

Henkin R, Schechter P, Hoye R, MATTERN C . Idiopathic hypogeusia with dysgeusia, hyposmia, and dysosmia. A new syndrome. JAMA. 1971; 217(4):434-40. View

18.

Deshpande T, Blanchard P, Wang L, Foote R, Zhang X, Frank S . Radiation-Related Alterations of Taste Function in Patients With Head and Neck Cancer: a Systematic Review. Curr Treat Options Oncol. 2018; 19(12):72. PMC: 6244914. DOI: 10.1007/s11864-018-0580-7. View

19.

Epstein J, de Andrade E Silva S, Epstein G, Leal J, Barasch A, Smutzer G . Taste disorders following cancer treatment: report of a case series. Support Care Cancer. 2019; 27(12):4587-4595. DOI: 10.1007/s00520-019-04758-5. View

20.

Walsh D, Rybicki L . Symptom clustering in advanced cancer. Support Care Cancer. 2006; 14(8):831-6. DOI: 10.1007/s00520-005-0899-z. View